课题基金 / 基金详情

ARC REGULATES MITOCHONDRIAL DEATH SIGNALING IN HEART

ARC REGULATES MITOCHONDRIAL DEATH SIGNALING IN HEART
ARC 调节心脏线粒体死亡信号
批准号:
7262545
负责人:
MICHAEL T CROW
金额:
$38.76万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-08-01 至 2009-07-31

项目摘要

项目成果

MICHAEL T CROW的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Cardiac cell loss is a prominent pathological feature associated with a number of cardiovascular disorders, including myocardial infarction, ischemia/reperfusion, chronic ischemia, and heart failure. ARC (Apoptosis Repressor with CARD/Caspase Recruitment Domain) is a recently identified muscle-specific repressor of cell death. It was originally identified as a protein that interacts with and regulates the activity of initiator caspase 8 which is associated with death receptor (TNFa, Fas) signaling. Our published and preliminary data indicate that there are additional targets for cardioprotection by ARC involving both caspase-dependent and -independent pathways. These targets are the intrinsic death signaling pathways of two major intracellular organelles, the mitochondria and the endoplasmic reticulum/Golgi complex. ARC is present in both subcellular fractions containing these organelles and staining reveals an association of ARC with the ER/developing sarcoplasmic reticulum (SR) of neonatal cardiomyocytes and a striated transverse distribution in adult cardiac muscle fibers that overlaps extensively with the SR. We hypothesize that ARCs structural association with the ER/SR and its close functional association with mitochondria are what is responsible for its ability to suppress a variety of intrinsic death stimuli, often intervening at the earliest stages in death signaling. In the mitochondria, we hypothesize that ARC interferes with BAX translocation/activation, while in the ER/SR it acts as an integral component of the protective arm of the endogenous ER stress response program. To test these hypotheses, we propose the following specific aims: Specific Aim #1 will define the molecular mechanism by which ARC inhibits BAX-induced and BAX associatedcell death as well as the functional significance of its association with a critical regulator of the mitochondrial fusion/fission apparatus. Specific Aim #2 will establish whether ARC is part of the ER stress response known as the unfolded protein response (UPR), what role it plays in ER preconditioning, and whether it suppresses the ER-specific initiator caspase 12. Specific Aim #3 will define ARC's role in regulating the apoptotic crosstalk between the ER/SR and mitochondrial death pathways through its effects on calcium dynamics and initiator caspase activation in response to hypoxia. The studies proposed will define the critical role of ARC in the management of the mitochondrial and ER/Golgi stress responses to cellular injury in the heart.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Determinants of Right Heart Failure In Severe PAH
  • 批准号:
    8013840
  • 项目类别:
  • 资助金额:
    $40.7万
  • 财政年份:
    2010
  • 负责人:
    MICHAEL T CROW
  • 依托单位:
Core--Molecular resources
  • 批准号:
    7347549
  • 项目类别:
  • 资助金额:
    $27.1万
  • 财政年份:
    2007
  • 负责人:
    MICHAEL T CROW
  • 依托单位:
Determinants of Right Heart Failure In Severe PAH
  • 批准号:
    7231194
  • 项目类别:
  • 资助金额:
    $42.14万
  • 财政年份:
    2006
  • 负责人:
    MICHAEL T CROW
  • 依托单位:
ARC REGULATES MITOCHONDRIAL DEATH SIGNALING IN HEART
  • 批准号:
    7093496
  • 项目类别:
  • 资助金额:
    $39.91万
  • 财政年份:
    2004
  • 负责人:
    MICHAEL T CROW
  • 依托单位:
国内基金
海外基金
TMEM8B-a 多聚化修饰降解 ATP2A2 蛋白抑制肺癌细胞集体侵袭的分子机制及靶向抑制剂转化应用研究
  • 批准号:
    2022JJ10096
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2022
  • 负责人:
    王理
  • 依托单位:
基于单细胞测序解析miR-4632靶向ATP2A2调控NLRP3焦亡信号促进肺动脉高压血管重塑的作用机制研究
  • 批准号:
    82241015
  • 项目类别:
    专项项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2022
  • 负责人:
    缪冉
  • 依托单位:
TMEM8B-a多聚化修饰降解ATP2A2蛋白抑制肺癌细胞集体侵袭的分子机制及相应靶向抑制剂转化应用研究
  • 批准号:
    82172879
  • 项目类别:
    面上项目
  • 资助金额:
    55万元
  • 批准年份:
    2021
  • 负责人:
    王理
  • 依托单位:
重度智力障碍并癫痫候选易感/致病基因ATP2A2、RYR1和RYR2分析验证及发病机制的研究
  • 批准号:
    81771408
  • 项目类别:
    面上项目
  • 资助金额:
    70.0万元
  • 批准年份:
    2017
  • 负责人:
    尹飞
  • 依托单位: